Insulet | PODD - 销售和管理费用

金融业

USD

USD 2.99B

现金及等价物

USD 480.4M

USD 232.7M

USD 1.71B

USD 687.5M

USD 949.2M

USD 122M

USD 181.7M

3.9K

EPS每股收益

USD 1.42

股本和储备

USD 1.3B

USD 540.8M

债务利息支出

USD 14.7M

USD 5.7M

USD 929.5M

USD 11.18B

USD 91.1M

USD 639.7M

USD 122M

普通股股本

USD 69.26M

38.83

USD 113M

USD 761.7M

销售和管理费用

USD 317.2M

USD 462.5M

贸易债权人

USD 149.8M

应收帐款人

USD 544.7M

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Align Technology	USD 465.34M		23.67M	2026-03
AtriCure	USD 84.55M		6.21M	2026-03
Avanos Medical	USD 77.7M		1.1M	2026-03
Baxter International	USD 728M		33M	2026-03
Becton, Dickinson and Co.	USD 1.21B		180M	2026-03
Boston Scientific	USD 1.78B		53M	2026-03
Cardinal Health	USD 1.51B		6M	2026-03
Cooper Companies	USD 676.2M		303.1M	2026-03
Dexcom	USD 349.7M		49.8M	2026-03
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Eli Lilly	USD 2.93B		198M	2026-03
Globus Medical	USD 297.77M		20.7M	2026-03
ICU Medical	USD 155.81M		3.04M	2025-12
Inogen	USD 43.77M		510K	2024-06
Insulet	USD 317.2M		14.2M	2026-03
Integra LifeSciences	USD 178.24M		21.79M	2026-03
J&J	USD 6.03B		719M	2026-03
Medtronic	2.96B		9M	2025-12
Merit Medical Systems	USD 110.47M		4.36M	2026-03
Roche Holding	CHF 7.28B		3.99B	2025-12
Solventum Corp	USD 783M		24M	2026-03
Stryker	USD 2.15B		17M	2026-03
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 226.01M		3.64M	2026-03
West Pharmaceutical Services	USD 99.5M		7M	2026-03
Zimmer Biomet Holdings	USD 849.9M		5.8M	2026-03